Drug firm Alembic Pharmaceuticals on Friday said it has raised ₹350 crore through allotment of non-convertible debentures (NCDs) on private placement basis.

“The NCD committee of Alembic Pharmaceuticals Ltd has allotted 1,500, 9 per cent rated unsecured listed redeemable non-convertible debentures (NCDs)... aggregating to ₹150 crore under tranche I,” Alembic Pharmaceuticals said in a regulatory filing.

The company said it has also allotted 2,000, 9 per cent rated unsecured listed redeemable NCDs aggregating to ₹200 crore.

Shares of Alembic Pharmaceuticals were trading 0.42 per cent lower at ₹615 on BSE.

social-fb COMMENT NOW